John Vong - 12 Dec 2022 Form 4 Insider Report for Apollo Medical Holdings, Inc. (ASTH)

Role
SVP-Chief Accounting Officer
Signature
/s/ John Vong
Issuer symbol
ASTH
Transactions as of
12 Dec 2022
Net transactions value
$0
Form type
4
Filing time
13 Dec 2022, 17:11:09 UTC
Previous filing
09 Dec 2022
Next filing
16 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMEH Common Stock Award $0 +1,388 +37% $0.000000 5,159 12 Dec 2022 Direct F1
transaction AMEH Common Stock Award $0 +1,388 +27% $0.000000 6,547 12 Dec 2022 Direct F2
transaction AMEH Common Stock Award $0 +694 +11% $0.000000 7,241 12 Dec 2022 Direct F3
transaction AMEH Common Stock Award $0 +694 +9.6% $0.000000 7,935 12 Dec 2022 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares of restricted stock shall vest in four equal annual installments beginning on November 30, 2023 and upon achievement of a pre-established performance goal on or before April 1, 2023.
F2 Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares of restricted stock shall vest in four equal annual installments beginning on November 30, 2023 and upon achievement of a pre-established performance goal on or before July 1, 2023.
F3 Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, 519 shares shall vest in three equal annual installments beginning on November 30, 2023. The remaining 175 shall vest on November 30, 2026. Such vesting is subject to achievement of a pre-established performance goal on or before April 1, 2023.
F4 Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, 519 shares shall vest in three equal annual installments beginning on November 30, 2023. The remaining 175 shall vest on November 30, 2026. Such vesting is subject to achievement of a pre-established performance goal on or before November 30, 2026.